Skip to main content
Premium Trial:

Request an Annual Quote

Rare, X-Linked Variants in DOCK11 Implicated in Handful of Patients

A team led by researchers at St. Anna Children's Cancer Research Institute in Vienna has identified rare, X-linked germline mutations in DOCK11 in a handful of patients with otherwise unexplained immune system and hematological symptoms. As they report in the New England Journal of Medicine, the researchers sequenced four male patients with similar presentations to uncover four hemizygous variants in the DOCK11 gene. DOCK11 is expressed largely in hematopoietic cells and, though it has a role in B cell development in mice, its role in people is mostly unknown. In a series of assays, the St. Anna's team found that while the DOCK11 gene variants they found affect B cell development, they also affect T cell development and lead to T cell overactivation, which can lead to organ damage. "The protein appears to play a role in keeping the activation of T cells within a certain range," first author Jana Block, a PhD student at St. Anna's and the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, says in a statement. Block and colleagues add that stem cell transplants or gene therapy could treat the disease, though more research is needed.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.